Jordan Kardos
Gilead Sciences (United States)(US)
Publications by Year
Research Areas
Bladder and Urothelial Cancer Treatments, Urinary and Genital Oncology Studies, Ferroptosis and cancer prognosis, Cancer Genomics and Diagnostics, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → A Consensus Molecular Classification of Muscle-invasive Bladder Cancer(2019)1,318 cited
- → Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy(2017)780 cited
- → The consensus molecular classification of muscle-invasive bladder cancer(2018)152 cited
- → Molecular Subtype-Specific Immunocompetent Models of High-Grade Urothelial Carcinoma Reveal Differential Neoantigen Expression and Response to Immunotherapy(2018)111 cited
- → MYC activation cooperates with Vhl and Ink4a/Arf loss to induce clear cell renal cell carcinoma(2017)86 cited
- → Intrinsic Genomic Differences Between African American and White Patients With Clear Cell Renal Cell Carcinoma(2016)78 cited
- → Phase II trial of palbociclib in patients with metastatic urothelial cancer after failure of first-line chemotherapy(2018)62 cited
- → The Cancer/Testes (CT) Antigen HORMAD1 promotes Homologous Recombinational DNA Repair and Radioresistance in Lung adenocarcinoma cells(2018)60 cited
- → Comprehensive Molecular Characterization of Urachal Adenocarcinoma Reveals Commonalities With Colorectal Cancer, Including a Hypermutable Phenotype(2017)48 cited
- → Molecular and Clinical Characterization of a Claudin-Low Subtype of Gastric Cancer(2017)17 cited